Reperfusion therapy is any treatment that restores blood flow to tissue that has been cut off from its blood supply. It is the primary emergency treatment for heart attacks and ischemic strokes, where a blood clot blocks an artery and starves heart muscle or brain tissue of oxygen. The goal is simple: reopen the blocked vessel as fast as possible to limit permanent damage.
Why Restoring Blood Flow Matters
When a blood clot blocks an artery, the tissue downstream begins to die within minutes. In the heart, this is a heart attack. In the brain, it’s an ischemic stroke. The cells deprived of oxygen shift into a survival mode that can only last so long before the damage becomes irreversible.
Around the core of dying tissue sits a zone called the ischemic penumbra, tissue that is injured and at risk but not yet dead. Reperfusion therapy targets this penumbra. If blood flow returns quickly enough, much of that at-risk tissue can recover. If it doesn’t, the penumbra becomes part of the permanent damage. This is why the phrase “time is muscle” (for heart attacks) and “time is brain” (for strokes) drives every decision in emergency treatment.
Reperfusion for Heart Attacks
For a type of heart attack called a STEMI (ST-elevation myocardial infarction), two main reperfusion strategies exist: a catheter-based procedure and clot-dissolving medications.
The preferred option is primary percutaneous coronary intervention, commonly called primary PCI or angioplasty. A cardiologist threads a thin catheter through an artery, typically starting at the groin or wrist, navigates it to the blocked coronary artery, and inflates a small balloon to reopen the vessel. A stent is usually placed to keep it open. Current guidelines from the American College of Cardiology and the American Heart Association set a goal of activating the device within 90 minutes of first medical contact for patients who arrive at or are transported to a hospital equipped for the procedure. For patients who must be transferred from a smaller hospital, the target extends to 120 minutes.
When PCI can’t be performed quickly enough, clot-dissolving drugs (fibrinolytics) are the alternative. These medications work by activating a natural enzyme that breaks down the fibrin holding a clot together. Fibrinolytic therapy has been a standard treatment for more than 20 years and is most effective within the first three hours of symptom onset. When available, starting fibrinolytics in the ambulance before reaching the hospital produces better outcomes than waiting until arrival.
The survival difference is striking. In a large study of STEMI patients, 30-day mortality was 12.9% for those who received PCI and 18.7% for those who received fibrinolytics alone, compared to 39.5% for patients who received no reperfusion therapy at all. At six months, the gap widened further: mortality reached 45.2% without reperfusion versus 16.6% with PCI.
Reperfusion for Ischemic Stroke
Stroke reperfusion follows a similar logic but uses different tools and timelines. The two main approaches are intravenous clot-dissolving drugs and mechanical thrombectomy.
Intravenous thrombolysis has been the backbone of stroke treatment since the mid-1990s. The standard drug, alteplase (also called tPA), binds to the fibrin in a blood clot and triggers a chain reaction that dissolves it. It significantly improves functional outcomes when given within 4.5 hours of symptom onset. A newer variant called tenecteplase offers a practical advantage: it can be given as a single injection rather than as a prolonged infusion, and recent evidence suggests it produces better clot-clearing results in patients with large vessel blockages. Updated 2026 guidelines now endorse thrombolysis in select patients up to 9 hours from symptom onset, or even up to 24 hours in certain cases, provided advanced brain imaging confirms there is still salvageable tissue.
Mechanical thrombectomy is a catheter-based procedure used when a large artery in the brain is blocked. A catheter is inserted through a puncture in the groin and guided up to the clot in the brain. From there, doctors use one of two main techniques. In the stent retriever approach, a small mesh device is deployed through the clot, grips it, and pulls it out. In the aspiration approach, a large catheter is advanced to the clot and suction is applied to extract it. An imaging scan is performed afterward to confirm the clot has been fully removed.
The clinical impact of thrombectomy is substantial. A pooled analysis of five major trials found that for every 2.6 patients treated with mechanical thrombectomy, one patient achieved a meaningful reduction in disability. Initially limited to the first six hours after symptom onset, the treatment window was extended in 2018 after two landmark trials demonstrated benefit up to 24 hours in carefully selected patients whose imaging showed recoverable brain tissue.
Who Can Receive These Treatments
Not everyone is a candidate for reperfusion therapy, particularly the drug-based approaches. Because clot-dissolving medications thin the blood aggressively, they carry a risk of serious bleeding. Absolute contraindications include active bleeding, a recent brain or spinal surgery, a history of bleeding in the brain, an ischemic stroke within the past three months, and known bleeding disorders.
Relative contraindications, situations where the treatment might still be given but requires careful judgment, include very high blood pressure (above 180/110), recent surgery, current use of blood thinners, and pregnancy. For mechanical thrombectomy in stroke, patients are typically selected based on the severity of their neurological symptoms, the location of the clot (usually a large artery at the base of the brain), and imaging evidence that enough brain tissue remains salvageable to justify the procedure.
The Paradox of Reperfusion Injury
Restoring blood flow is lifesaving, but the process itself can cause a secondary wave of damage known as reperfusion injury. This is one of the central paradoxes of emergency medicine: the treatment that rescues tissue also, to some degree, harms it.
Here’s what happens at the cellular level. During the period without blood flow, cells accumulate acid and other waste products. When oxygen-rich blood suddenly returns, it triggers a cascade of harmful events. The rapid correction of the acidic environment inside cells leads to a buildup of calcium, which can overwhelm and kill cells. At the same time, mitochondria (the energy-producing structures inside cells) become destabilized. Pores in the mitochondrial membrane that stayed closed during the period of oxygen deprivation snap open within minutes of blood flow returning, flooding the cell with damaging molecules.
This process generates a surge of reactive oxygen species, highly unstable molecules that damage DNA, proteins, and cell membranes. The damaged cells then release inflammatory signals that attract white blood cells into the injured area. These arrive within the first six hours and migrate deeper into the tissue over the next 24 hours, amplifying inflammation and causing further destruction.
One visible consequence in the heart is called myocardial stunning. The heart’s energy production returns to normal within seconds of blood flow restoration, but the muscle’s ability to contract lags behind and only gradually recovers. The stunned muscle uses more oxygen than it should for the amount of work it’s doing, making it temporarily inefficient.
Despite this secondary damage, the net benefit of reperfusion therapy is overwhelmingly positive. The tissue saved by restoring blood flow far outweighs the tissue lost to reperfusion injury. Reducing the time to treatment minimizes both the initial damage from oxygen deprivation and the severity of reperfusion injury that follows.
Why Every Minute Counts
The single most important factor in reperfusion therapy outcomes is speed. In heart attacks, every 30-minute delay in opening the blocked artery increases mortality. In stroke, an estimated 1.9 million neurons are lost per minute during a large vessel blockage. The entire emergency system, from paramedic protocols to hospital workflows, is designed around compressing the time between symptom onset and vessel reopening.
This is why recognizing symptoms early matters so much. For heart attacks, that means chest pain or pressure, shortness of breath, and pain radiating to the arm, jaw, or back. For strokes, the hallmarks are sudden facial drooping, arm weakness, and difficulty speaking. Calling emergency services immediately, rather than driving to the hospital, allows paramedics to begin assessment in transit and alert the receiving hospital to prepare the catheterization lab or stroke team before the patient arrives.